"607213" . . . "GB - Spojen\u00E9 kr\u00E1lovstv\u00ED Velk\u00E9 Brit\u00E1nie a Severn\u00EDho Irska" . "Faitov\u00E1, Jitka" . . . "FGF-2 expression and its action in human leukemia and lymphoma cell lines."@en . "Dvo\u0159\u00E1k, Petr" . "3"^^ . . . "FGF-2 expression and its action in human leukemia and lymphoma cell lines." . "FGF-2 expression and its action in human leukemia and lymphoma cell lines."@en . "RIV/68378041:_____/03:19033057!RIV/2004/AV0/A19004/N" . "Laurell, H." . "It was shown that while the majority of human leukemia and lymphoma cell lines synthesizes low molecular mass FGF-2, its release is generally insufficient. However, several cell lines display prerequisites to respond to the extracellular FGF-2 that could be produced by other cell types. Importantly, in a majority of cell lines was found concomitant expression of two potent antiapoptotic molecules, high molecular mass FGF-2 and FGF-2-interacting protein FIF. This opens the possibility of their participation in the regulation of apoptosis."@en . "0887-6924" . . "FGF-2 expression and its action in human leukemia and lymphoma cell lines." . . . "leukemia"@en . . . "3"^^ . "It was shown that while the majority of human leukemia and lymphoma cell lines synthesizes low molecular mass FGF-2, its release is generally insufficient. However, several cell lines display prerequisites to respond to the extracellular FGF-2 that could be produced by other cell types. Importantly, in a majority of cell lines was found concomitant expression of two potent antiapoptotic molecules, high molecular mass FGF-2 and FGF-2-interacting protein FIF. This opens the possibility of their participation in the regulation of apoptosis." . "N/A" . . "0"^^ . "P(LN00A065), P(ME 198), Z(AV0Z5039906), Z(MSM 432100001)" . "0"^^ . "Krej\u010D\u00ED, P." . . "Hampl, Ale\u0161" . "818;820" . . "Leukemia" . . . . . "5"^^ . "17" . "RIV/68378041:_____/03:19033057" . . "[F94E8100BE05]" .